- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04594564
Squeaking in Ceramic-on-Ceramic Total Hip Arthroplasty Using Delta TT Cup
October 24, 2022 updated by: Young-Kyun Lee, Seoul National University Hospital
This study will evaluate clinical outcome on patients who undergo ceramic on ceramic (CoC) bearing total hip arthroplasty (THA) using Delta TT cup.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
This study will evaluate clinical outcome on patients who undergo ceramic on ceramic (CoC) bearing total hip arthroplasty (THA) using Delta TT cup. Specifically the study intends to address the following research topics:
- The incidence of squeaking after CoC THA using Delta TT cup.
- The dislocation rate and survival rate of CoC THA using Delta TT cup.
Study Type
Observational
Enrollment (Anticipated)
270
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Gyeonggi-do
-
Seongnam, Gyeonggi-do, Korea, Republic of, 13620
- Recruiting
- Seoul National University Bundang Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Those who undergo THA for their advanced hip disease.
Description
Inclusion Criteria:
- Older than 18 years old
- Non-inflammatory degenerative joint disease such as osteoarthritis or avascular necrosis
- Rheumatoid arthritis
- Post-traumatic arthritis
- Fractures of femoral neck
Exclusion Criteria:
- Local or systemic infection
- Septicaemia
- Persistent acute or chronic osteomyelitis
- Confirmed nerve or muscle lesion compromising hip joint function
- Unstable medical illness
- Rapidly progressive neurological disease
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Squeaking
Time Frame: 6 weeks
|
Rate of any noise after THA
|
6 weeks
|
Squeaking
Time Frame: 3 months
|
Rate of any noise after THA
|
3 months
|
Squeaking
Time Frame: 6 months
|
Rate of any noise after THA
|
6 months
|
Squeaking
Time Frame: 9 months
|
Rate of any noise after THA
|
9 months
|
Squeaking
Time Frame: 12 months
|
Rate of any noise after THA
|
12 months
|
Squeaking
Time Frame: 24 months
|
Rate of any noise after THA
|
24 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Dislocation
Time Frame: 6 weeks
|
Dislocation rate after THA
|
6 weeks
|
Dislocation
Time Frame: 3 months
|
Dislocation rate after THA
|
3 months
|
Dislocation
Time Frame: 6 months
|
Dislocation rate after THA
|
6 months
|
Dislocation
Time Frame: 9 months
|
Dislocation rate after THA
|
9 months
|
Dislocation
Time Frame: 12 months
|
Dislocation rate after THA
|
12 months
|
Dislocation
Time Frame: 24 months
|
Dislocation rate after THA
|
24 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Range of motion
Time Frame: 24 months
|
Change of range of motion after THA
|
24 months
|
Survivorship of implant
Time Frame: 24 months
|
Survival rate of prosthesis
|
24 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
October 1, 2020
Primary Completion (ANTICIPATED)
December 31, 2023
Study Completion (ANTICIPATED)
December 31, 2023
Study Registration Dates
First Submitted
October 13, 2020
First Submitted That Met QC Criteria
October 13, 2020
First Posted (ACTUAL)
October 20, 2020
Study Record Updates
Last Update Posted (ACTUAL)
October 26, 2022
Last Update Submitted That Met QC Criteria
October 24, 2022
Last Verified
October 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Delta TT cup
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Osteoarthritis, Hip
-
Istituto Ortopedico RizzoliRecruiting
-
University of California, San FranciscoStanford University; Robert Wood Johnson FoundationCompletedKnee Osteoarthritis | Hip OsteoarthritisUnited States
-
CHU de ReimsCompleted
-
Royan InstituteCompletedHip OsteoarthritisIran, Islamic Republic of
-
Daiichi Sankyo, Inc.TerminatedSymptomatic Hip OsteoarthritisFrance
-
University of VermontCompletedOsteoarthritis of Knee | Osteoarthritis Of HipUnited States
-
Oxford University Hospitals NHS TrustCompletedKnee Osteoarthritis | Hip Osteoarthritis | Knee Arthroplasty | Hip ArthroplastyUnited Kingdom
-
Johan KarrholmCompletedPrimary Osteoarthritis of Hip Nos | Secondary Osteoarthritis of Hip
-
University of ArkansasCompletedKnee Osteoarthritis | Hip Osteoarthritis | Knee Arthritis | Hip ArthritisUnited States
-
Lawson Health Research InstituteCompletedHip Osteoarthritis | Hip ArthroplastyCanada
Clinical Trials on Total hip arthroplasty with Delta TT cup
-
Korea University Guro HospitalStryker Korea Co., Ltd.Active, not recruitingArthroplasty Complications | Femur Neck FractureKorea, Republic of
-
JointResearchCompleted
-
Limacorporate S.p.aCompletedPrimary Total Hip ReplacementItaly
-
Iuliu Hatieganu University of Medicine and PharmacyRecruiting
-
Zimmer BiometEnrolling by invitationOsteoarthritis | Avascular Necrosis | Traumatic Arthritis | Slipped Capital Femoral Epiphyses | Non-inflammatory Degenerative Joint Disease (NIDJD) | Protrusio Acetabuli | Fracture of the Pelvis | Diastrophic Variant | Fused HipUnited States
-
Smith & Nephew, Inc.RecruitingAdvanced Degeneration of the Hip Joint | Revision of the Hip JointUnited States, Canada, Australia, Hong Kong, India
-
Limacorporate S.p.aActive, not recruiting
-
Suzhou MicroPort OrthoRecon Co. LTDCompleted
-
Aesculap AGRecruitingCoxarthrosis; PrimaryCzechia
-
Orthopedic Hospital Vienna SpeisingCompletedTotal Hip ArthroplastyAustria